
Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients.
Author(s) -
Gérald Simonneau,
Marius M. Hoeper,
Hossein Ardeschir Ghofrani,
Paul A. Corris,
Stephan Rosenkranz,
Ekkehard Grüning,
R. James White,
Vallerie V. McLaughlin,
David Langleben,
Christian Meier,
Dennis Busse,
Frank Kleinjung,
Raymond L. Benza
Publication year - 2020
Publication title -
revista colombiana de neumologia/revista colombiana de neumología
Language(s) - English
Resource type - Journals
eISSN - 2538-9513
pISSN - 0121-5426
DOI - 10.30789/rcneumologia.v31.n2.2019.451
Subject(s) - riociguat , term (time) , association (psychology) , composite number , medicine , psychology , materials science , composite material , guanylate cyclase , physics , quantum mechanics , nitric oxide , psychotherapist
Assessment of the REPLACE study composite endpoint in the PATENT